Quick Answer
ABVC BIOPHARMA, INC. reported Total Assets of $21.06 million for the year ending 2025.
- ABVC BIOPHARMA, INC. showed an increase of +179.3% in Total Assets from 2024 to 2025.
- This data is from ABVC BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $302.3 thousand | Q4 2012: $271.8 thousand | Q1 2013: $251.3 thousand | Q2 2013: $232.0 thousand | Q3 2013: $232.0 thousand | Q4 2013: $232.0 thousand | Q1 2014: $231.9 thousand | Q2 2014: $231.9 thousand | Q4 2014: $64.6 thousand | Q1 2015: $64.6 thousand | Q2 2015: $67.3 thousand | Q4 2015: $64.9 thousand | Q2 2016: $3.59 million | Q4 2016: $18.6 thousand | Q1 2017: $106.4 thousand | Q2 2017: $8.1 thousand | Q1 2018: $2.56 million | Q2 2018: $2.65 million | Q3 2018: $2.59 million | Q1 2019: $7.45 million | Q2 2019: $7.14 million | Q3 2019: $7.40 million | Q1 2020: $6.67 million | Q2 2020: $6.43 million | Q3 2020: $6.53 million | Q1 2021: $10.53 million | Q2 2021: $8.94 million | Q3 2021: $12.35 million | Q1 2022: $12.07 million | Q2 2022: $13.78 million | Q3 2022: $10.48 million | Q1 2023: $10.73 million | Q2 2023: $9.32 million | Q3 2023: $16.59 million | Q1 2024: $7.98 million | Q2 2024: $8.04 million | Q3 2024: $7.78 million | Q1 2025: $14.88 million | Q2 2025: $16.24 million | Q3 2025: $21.18 million.
- Over the full 16 years of available data (2011 to 2025), ABVC BIOPHARMA, INC.'s Total Assets has grown by 5,601.8%.
- Historical annual values: Fiscal year 2025: $21.06 million | Fiscal year 2024: $7.54 million | Fiscal year 2023: $7.78 million | Fiscal year 2022: $9.58 million | Fiscal year 2021: $13.70 million | Fiscal year 2020: $11.61 million | Fiscal year 2019: $6.93 million | Fiscal year 2018: $5.94 million | Fiscal year 2017: $2.64 million | Fiscal year 2017: $2.75 million | Fiscal year 2016: $177.4 thousand | Fiscal year 2015: $1.00 million | Fiscal year 2014: $65.4 thousand | Fiscal year 2013: $232.0 thousand | Fiscal year 2012: $302.3 thousand | Fiscal year 2011: $369.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: